Abstract No. 615 Lusutrombopag is a safe and efficacious treatment option for thrombocytopenia in patients with chronic liver disease undergoing planned invasive procedures: integrated analysis of two phase 3 trials

Authors :: R. Bentley
Michio Imawari
Markus Peck-Radosavljevic
T. Kano
Y. Osaki
T. Ochiai
Robert S. Brown
N. Izumi
Source :: Journal of Vascular and Interventional Radiology. 31:S266-S267
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: medicine.medical_specialty
business.industry
medicine
Treatment options
Radiology, Nuclear Medicine and imaging
In patient
Cardiology and Cardiovascular Medicine
Chronic liver disease
medicine.disease
business
Phase (combat)
Lusutrombopag
Surgery

Full Text Access

Tools